{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Esteve Pharmaceuticals S.A., Barcelona, Spain.",
    "York Health Economics Consortium, University of York, York, United Kingdom."
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Arnau Domenech"
    },
    {
      "affs": [
        0
      ],
      "name": "Martí Hopmans"
    },
    {
      "affs": [
        1
      ],
      "name": "Erin Barker"
    },
    {
      "affs": [
        1
      ],
      "name": "Joe W E Moss"
    },
    {
      "affs": [
        0
      ],
      "name": "Montserrat Carrasco"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/2krasmxgj27m9.bib",
  "cited_by": 0,
  "doi": "10.3389/fendo.2026.1979615",
  "fulltext_url": "https://europepmc.org/articles/PMC13677545",
  "id": "2krasmxgj27m9",
  "issns": [
    "1664-2392"
  ],
  "landing_url": "https://europepmc.org/article/MED/42898225",
  "language": "eng",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2712|Thyroid Cancer Diagnosis and Treatment"
    ]
  ],
  "openalex": "W7219892160",
  "pdf_url": "https://europepmc.org/articles/PMC13677545?pdf=render",
  "pmcid": "PMC13677545",
  "pmid": "42898225",
  "published": "2026-10-05",
  "publisher": "Frontiers Media SA",
  "ris": "https://research.draconitic.com/paper/2krasmxgj27m9.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:19:37Z",
      "native_id": "MED:42898225",
      "source": "europepmc",
      "url": "https://europepmc.org/article/MED/42898225"
    },
    {
      "first_seen": "2026-10-30T12:20:20Z",
      "native_id": "10.3389/fendo.2026.1979615",
      "source": "crossref",
      "url": "https://www.frontiersin.org/articles/10.3389/fendo.2026.1979615/full"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2712|Thyroid Cancer Diagnosis and Treatment",
      "subfield": "endocrinology-metabolism"
    }
  ],
  "title": "Commentary: Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: a network meta-analysis of RET-targeted therapies.",
  "title_text": "Commentary: Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: a network meta-analysis of RET-targeted therapies.",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:20:20Z",
  "url": "https://research.draconitic.com/paper/2krasmxgj27m9",
  "venue": "Frontiers in endocrinology",
  "versions": []
}